"The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is the first drug approved by the FDA for this condition.
Argatroban Patient Information including How Should I Take
In this Article
- What is argatroban (Argatroban)?
- What are the possible side effects of argatroban (Argatroban)?
- What is the most important information I should know about argatroban (Argatroban)?
- What should I discuss with my health care provider before receiving argatroban (Argatroban)?
- How is argatroban given (Argatroban)?
- What happens if I miss a dose (Argatroban)?
- What happens if I overdose (Argatroban)?
- What should I avoid while receiving argatroban (Argatroban)?
- What other drugs will affect argatroban (Argatroban)?
- Where can I get more information?
What should I discuss with my health care provider before receiving argatroban (Argatroban)?
You should not receive this medication if you are allergic to argatroban, or if you have any major bleeding from a surgery, injury, or other medical trauma.
To make sure you can safely use argatroban, tell your doctor if you have any of these other conditions:
- a stomach ulcer or bleeding;
- liver disease;
- a bleeding or blood clotting disorder (such as hemophilia);
- untreated or uncontrolled high blood pressure (hypertension);
- if you have recently had a spinal tap or epidural anesthesia; or
- if you have recently had major surgery (especially eye surgery, brain surgery, or spinal cord surgery).
Argatroban is not expected to be harmful to an unborn baby. However, aspirin is sometimes given with argatroban, and aspirin can cause bleeding when it is taken during the last 3 months of pregnancy. Aspirin can also cause side effects in a newborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether argatroban passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.
How is argatroban given (Argatroban)?
Argatroban is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Argatroban is sometimes given together with aspirin.
If you are receiving this injection during an angioplasty procedure, the medicine will be given throughout the entire procedure and for up to 24 hours after the procedure.
Argatroban is given around the clock until your blood coagulates properly. Your doctor will test your blood often to determine how long to treat you with argatroban.
To be sure this medicine is helping your condition and is not causing harmful effects, your blood will need to be tested often. Visit your doctor regularly.
Because argatroban keeps your blood from coagulating (clotting) to prevent unwanted blood clots, it can also make it easier for you to bleed, even from a minor injury. Contact your doctor or seek emergency medical attention if you have bleeding that will not stop.
Additional Argatroban Information
Argatroban - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.